Get started
Regencell Bioscience Holdings LimitedRegencell Bioscience Holdings LimitedRegencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsSeasonalsETFs

Fundamentals and stats

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
RGC has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company